Current perspectives of sudden cardiac death management in hypertrophic cardiomyopathy

被引：2
作者：
Pu, Lutong [1 ]
Li, Jialin [1 ]
Qi, Weitang [1 ]
Zhang, Jinquan [2 ]
Chen, Hongyu [2 ]
Tang, Zihuan [2 ]
Han, Yuchi [3 ]
Wang, Jie [1 ]
Chen, Yucheng [1 ,4 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Cardiol, Guoxue Xiang 37, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China
[3] Ohio State Univ, Coll Med, Wexner Med Ctr, Columbus, OH USA
[4] Sichuan Univ, West China Hosp, Ctr Rare Dis, Chengdu 610041, Sichuan, Peoples R China
来源：
HEART FAILURE REVIEWS | 2024年 / 29卷 / 02期
基金：
中国国家自然科学基金;
关键词：
Hypertrophic cardiomyopathy; Sudden cardiac death; Cardiovascular magnetic resonance; Prognosis; RISK STRATIFICATION; PROGNOSTIC VALUE; GENE-MUTATIONS; PREVENTION; GUIDELINES; CONSEQUENCES; DYSFUNCTION; CARDIOLOGY; SARCOMERE; DIAGNOSIS;
D O I：
10.1007/s10741-023-10355-w
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disorder characterized by left ventricular hypertrophy. Sudden cardiac death (SCD) is a rare but the most catastrophic complication in patients with HCM. Implantable cardioverter-defibrillators (ICDs) are widely recognized as effective preventive measures for SCD. Individualized risk stratification and early intervention in HCM can significantly improve patient prognosis. In this study, we review the latest findings regarding pathogenesis, risk stratification, and prevention of SCD in HCM patients, highlighting the clinic practice of cardiovascular magnetic resonance imaging for SCD management.
引用
收藏
页码：395 / 404
页数：10
相关论文
共 65 条
[41]   2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease (Feb, 10.1093/eurheartj/ehaa605 2020) [J].
Pelliccia, A. .
EUROPEAN HEART JOURNAL, 2021, 42 (05) :548-549
[42]   Does Sport Participation Worsen the Clinical Course of Hypertrophic Cardiomyopathy? Clinical Outcome of Hypertrophic Cardiomyopathy in Athletes [J].
Pelliccia, Antonio ;
Lemme, Erika ;
Maestrini, Viviana ;
Di Paolo, Fernando M. ;
Pisicchio, Cataldo ;
Di Gioia, Giuseppe ;
Caselli, Stefano .
CIRCULATION, 2018, 137 (05) :531-533
[43]   Microvascular Dysfunction in Hypertrophic Cardiomyopathy [J].
Pelliccia, Francesco ;
Cecchi, Franco ;
Olivotto, Iacopo ;
Camici, Paolo G. .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (21)
[44]   MUSCULAR SUB-AORTIC STENOSIS - HEMODYNAMIC AND CLINICAL IMPROVEMENT AFTER DISOPYRAMIDE [J].
POLLICK, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (16) :997-999
[45]   Gene therapy strategies in the treatment of hypertrophic cardiomyopathy [J].
Prondzynski, Maksymilian ;
Mearini, Giulia ;
Carrier, Lucie .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2019, 471 (05) :807-815
[46]   Incremental Values of T1 Mapping in the Prediction of Sudden Cardiac Death Risk in Hypertrophic Cardiomyopathy: A Comparison With Two Guidelines [J].
Qin, Le ;
Min, Jiehua ;
Chen, Chihua ;
Zhu, Lan ;
Gu, Shengjia ;
Zhou, Mi ;
Yang, Wenjie ;
Yan, Fuhua .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
[47]   Advanced imaging for risk stratification of sudden death in hypertrophic cardiomyopathy [J].
Ramchand, Jay ;
Fava, Agostina M. ;
Chetrit, Michael ;
Desai, Milind Y. .
HEART, 2020, 106 (11) :793-801
[48]   Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm Implications for Risk Stratification and Management [J].
Rowin, Ethan J. ;
Maron, Barry J. ;
Haas, Tammy S. ;
Garberich, Ross F. ;
Wang, Weijia ;
Link, Mark S. ;
Maron, Martin S. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (07) :761-773
[49]   Identifying Sarcomere Gene Mutations in Hypertrophic Cardiomyopathy A Personal History [J].
Seidman, Christine E. ;
Seidman, J. G. .
CIRCULATION RESEARCH, 2011, 108 (06) :743-750
[50]   New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy [J].
Semsarian, Christopher ;
Ingles, Jodie ;
Maron, Martin S. ;
Maron, Barry J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (12) :1249-1254
1234567